National Academies Press: OpenBook
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

THE LEARNING HEALTHCARE SYSTEM SERIES


ROUNDTABLE ON VALUE & SCIENCE-DRIVEN HEALTH CARE

VALUE IN HEALTH CARE

Accounting for Cost, Quality, Safety, Outcomes, and Innovation

Workshop Summary

Pierre L. Yong, LeighAnne Olsen, and J. Michael McGinnis

INSTITUTE OF MEDICINE
OF THE NATIONAL ACADEMIES

THE NATIONAL ACADEMIES PRESS

Washington, D.C.
www.nap.edu

Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

THE NATIONAL ACADEMIES PRESS
500 Fifth Street, N.W.
Washington, DC 20001

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine.


This project was supported by the Agency for Healthcare Research and Quality, America’s Health Insurance Plans, AstraZeneca, Blue Shield of California Foundation, Burroughs Wellcome Fund, California Health Care Foundation, Centers for Medicare and Medicaid Services, Department of Veterans Affairs, Food and Drug Administration, Johnson & Johnson, the Moore Foundation, the National Institutes of Health, sanofi-aventis, and Stryker. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that provided support for this project.

International Standard Book Number 13: 978-0-309-12182-8

International Standard Book Number 10: 0-309-12182-5

Additional copies of this report are available from the

National Academies Press,

500 Fifth Street, N.W., Lockbox 285, Washington, DC 20055; (800) 624-6242 or (202) 334-3313 (in the Washington metropolitan area); Internet, http://www.nap.edu.

For more information about the Institute of Medicine, visit the IOM home page at: www.iom.edu.

Copyright 2010 by the National Academy of Sciences. All rights reserved.

Printed in the United States of America

The serpent has been a symbol of long life, healing, and knowledge among almost all cultures and religions since the beginning of recorded history. The serpent adopted as a logotype by the Institute of Medicine is a relief carving from ancient Greece, now held by the Staatliche Museen in Berlin.

Suggested citation: IOM (Institute of Medicine). 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes and Innovation: Workshop Summary. Washington, DC: The National Academies Press.

Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

“Knowing is not enough; we must apply.

Willing is not enough; we must do.”

—Goethe

INSTITUTE OF MEDICINE
OF THE NATIONAL ACADEMIES

Advising the Nation. Improving Health.

Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

THE NATIONAL ACADEMIES

Advisers to the Nation on Science, Engineering, and Medicine


The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare. Upon the authority of the charter granted to it by the Congress in 1863, the Academy has a mandate that requires it to advise the federal government on scientific and technical matters. Dr. Ralph J. Cicerone is president of the National Academy of Sciences.


The National Academy of Engineering was established in 1964, under the charter of the National Academy of Sciences, as a parallel organization of outstanding engineers. It is autonomous in its administration and in the selection of its members, sharing with the National Academy of Sciences the responsibility for advising the federal government. The National Academy of Engineering also sponsors engineering programs aimed at meeting national needs, encourages education and research, and recognizes the superior achievements of engineers. Dr. Charles M. Vest is president of the National Academy of Engineering.


The Institute of Medicine was established in 1970 by the National Academy of Sciences to secure the services of eminent members of appropriate professions in the examination of policy matters pertaining to the health of the public. The Institute acts under the responsibility given to the National Academy of Sciences by its congressional charter to be an adviser to the federal government and, upon its own initiative, to identify issues of medical care, research, and education. Dr. Harvey V. Fineberg is president of the Institute of Medicine.


The National Research Council was organized by the National Academy of Sciences in 1916 to associate the broad community of science and technology with the Academy’s purposes of furthering knowledge and advising the federal government. Functioning in accordance with general policies determined by the Academy, the Council has become the principal operating agency of both the National Academy of Sciences and the National Academy of Engineering in providing services to the government, the public, and the scientific and engineering communities. The Council is administered jointly by both Academies and the Institute of Medicine. Dr. Ralph J. Cicerone and Dr. Charles M. Vest are chair and vice chair, respectively, of the National Research Council.


www.national-academies.org

Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

ROUNDTABLE ON VALUE & SCIENCE-DRIVEN HEALTH CARE1

Denis A. Cortese (Chair), Emeritus President and Chief Executive Officer,

Mayo Clinic;

Foundation Professor,

ASU

David Blumenthal, National Coordinator,

Office of the National Coordinator for Health IT (ex officio)

Bruce G. Bodaken, Chairman, President, and Chief Executive Officer,

Blue Shield of California

David R. Brennan, Chief Executive Officer,

AstraZeneca PLC

Paul Chew, Chief Science Officer and CMO,

sanofi-aventis U.S., Inc.

Carolyn M. Clancy, Director,

Agency for Healthcare Research and Quality (ex officio)

Francis Collins, Director,

National Institutes of Health (designee: Susan Shurin) (ex officio)

Michael J. Critelli, Former Executive Chairman,

Pitney Bowes, Inc.

Helen Darling, President,

National Business Group on Health

Thomas R. Frieden, Director,

Centers for Disease Control and Prevention (ex officio)

Gary L. Gottlieb, President and CEO,

Partners HealthCare System

James A. Guest, President,

Consumers Union

George C. Halvorson, Chairman and Chief Executive Officer,

Kaiser Permanente

Margaret A. Hamburg, Commissioner,

Food and Drug Administration (ex officio)

Carmen Hooker Odom, President,

Milbank Memorial Fund

Ardis Hoven, Professor of Medicine,

University of Kentucky;

Chair-elect,

American Medical Association

Brent James, Chief Quality Officer and Executive Director,

Institute for Health Care Delivery Research, Intermountain Healthcare

Michael M. E. Johns, Chancellor,

Emory University

Craig Jones, Director,

Vermont Blueprint for Health

Cato T. Laurencin, Vice President for Health Affairs, Dean of the School of Medicine,

U. of Connecticut

Stephen P. MacMillan, President and Chief Executive Officer,

Stryker

Mark B. McClellan, Director,

Engelberg Center for Healthcare Reform, The Brookings Institution

Sheri S. McCoy, Worldwide Chairman,

Johnson & Johnson Pharmaceuticals Group

1

Formerly the Roundtable on Evidence-Based Medicine. IOM forums and roundtables do not issue, review, or approve individual documents. The responsibility for the published workshop summary rests with the workshop rapporteur and the institution.

Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

Mary D. Naylor, Professor and Director of Center for Transitions in Health,

University of Pennsylvania

Peter Neupert, Corporate Vice President,

Health Solutions Group, Microsoft Corporation

Nancy H. Nielsen, Past President,

American Medical Association

William D. Novelli, Former CEO,

AARP;

Professor,

Georgetown University

Jonathan B. Perlin, Chief Medical Officer and President,

Clinical Services, HCA, Inc.

Robert A. Petzel, Under Secretary,

Veterans Health Administration (designee: Joel Kupersmith) (ex officio)

Richard Platt, Professor and Chair,

Harvard Medical School and Harvard Pilgrim Health Care

John C. Rother, Group Executive Officer,

AARP

John W. Rowe, Professor,

Mailman School of Public Health, Columbia University

Mark D. Smith, President and CEO,

California HealthCare Foundation

Reed D. Tuckson, Executive VP and Chief of Medical Affairs,

UnitedHealth Group

Frances M. Visco, President,

National Breast Cancer Coalition

Administrator,

Centers for Medicare and Medicaid Services (ex officio)

Assistant Secretary for Health Affairs,

Department of Defense (ex officio)

Planning Committee

Michael E. Chernew,

Harvard Medical School

Ezekiel J. Emanuel,

National Institutes of Health

Arthur Garson, Jr.,

University of Virginia School of Medicine

Samuel R. Nussbaum,

Wellpoint

John C. Rother,

AARP

Karen L. Smith,

AstraZeneca

Roundtable Staff

Christie Bell, Financial Associate

Patrick Burke, Financial Associate (through December 2009)

Andrea Cohen, Financial Associate (through December 2008)

Kiran Gupta, Research Assistant

J. Michael McGinnis, Senior Scholar and Executive Director

LeighAnne Olsen, Program Officer

Daniel O’Neill, Research Associate (through January 2009)

Kate Sharaf, Fellow (through November 2008)

Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

Ruth Strommen, Intern

Kate Vasconi, Program Assistant

Pierre L. Yong, Program Officer

Allen Zheng, Intern

Catherine Zweig, Senior Program Assistant

Page viii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

This page intentionally left blank.

Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

Reviewers

This report has been reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise, in accordance with procedures approved by the National Research Council’s Report Review Committee. The purpose of this independent review is to provide candid and critical comments that will assist the institution in making its published report as sound as possible and to ensure that the report meets institutional standards for objectivity, evidence, and responsiveness to the study charge. The review comments and draft manuscript remain confidential to protect the integrity of the process. We wish to thank the following individuals for their review of this report:

Michael Chernew, Harvard Medical School

Mary Kay Henry, SEIU

Ronald A. Paulus, Geisinger Health System

Vincenza Snow, American College of Physicians

Although the reviewers listed above have provided many constructive comments and suggestions, they were not asked to endorse the final draft of the report before its release. The review of this report was overseen by Robert Graham, University of Cincinnati College of Medicine. Appointed by the National Research Council and the Institute of Medicine, he was responsible for making certain that an independent examination of this report was carried out in accordance with institutional procedures and that all review comments were carefully considered. Responsibility for the final content of this report rests entirely with the editors and the institution.

Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

This page intentionally left blank.

Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

Institute of Medicine

Roundtable on Value & Science-Driven Health Care

Charter and Vision Statement


The Institute of Medicine’s Roundtable on Value & Science-Driven Health Care has been convened to help transform the way evidence on clinical effectiveness is generated and used to improve health and health care. Participants have set a goal that, by the year 2020, 90 percent of clinical decisions will be supported by accurate, timely, and up-to-date clinical information, and will reflect the best available evidence. Roundtable members will work with their colleagues to identify the issues not being adequately addressed, the nature of the barriers and possible solutions, and the priorities for action, and will marshal the resources of the sectors represented on the Roundtable to work for sustained public-private cooperation for change.


******************************************


The Institute of Medicine’s Roundtable on Value & Science-Driven Health Care has been convened to help transform the way evidence on clinical effectiveness is generated and used to improve health and health care. We seek the development of a learning healthcare system that is designed to generate and apply the best evidence for the collaborative healthcare choices of each patient and provider; to drive the process of discovery as a natural outgrowth of patient care; and to ensure innovation, quality, safety, and value in health care.

Vision: Our vision is for a healthcare system that draws on the best evidence to provide the care most appropriate to each patient, emphasizes prevention and health promotion, delivers the most value, adds to learning throughout the delivery of care, and leads to improvements in the nation’s health.

Goal: By the year 2020, 90 percent of clinical decisions will be supported by accurate, timely, and up-to-date clinical information, and will reflect the best available evidence. We feel that this presents a tangible focus for progress toward our vision, that Americans ought to expect at least this level of performance, that it should be feasible with existing resources and emerging tools, and that measures can be developed to track and stimulate progress.

Context: As unprecedented developments in the diagnosis, treatment, and long-term management of disease bring Americans closer than ever to the promise of personalized health care, we are faced with similarly unprecedented challenges to identify and deliver the care most appropriate for individual needs and conditions. Care that is important is often not delivered. Care that is delivered is often not important. In part, this is due to our failure to apply the evidence we have about the medical care that is most effective—a failure related to shortfalls in provider knowledge and accountability, inadequate care coordination and support, lack of insurance, poorly aligned payment incen

Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

tives, and misplaced patient expectations. Increasingly, it is also a result of our limited capacity for timely generation of evidence on the relative effectiveness, efficiency, and safety of available and emerging interventions. Improving the value of the return on our healthcare investment is a vital imperative that will require much greater capacity to evaluate high-priority clinical interventions, stronger links between clinical research and practice, and reorientation of the incentives to apply new insights. We must quicken our efforts to position evidence development and application as natural outgrowths of clinical care—to foster health care that learns.

Approach: The IOM Roundtable on Value & Science-Driven Health Care serves as a forum to facilitate the collaborative assessment and action around issues central to achieving the vision and goal stated. The challenges are myriad and include issues that must be addressed to improve evidence development, evidence application, and the capacity to advance progress on both dimensions. To address these challenges, as leaders in their fields, Roundtable members will work with their colleagues to identify the issues not being adequately addressed, the nature of the barriers and possible solutions, and the priorities for action, and will marshal the resources of the sectors represented on the Roundtable to work for sustained public-private cooperation for change.

Activities include collaborative exploration of new and expedited approaches to assessing the effectiveness of diagnostic and treatment interventions, better use of the patient care experience to generate evidence on effectiveness, identification of assessment priorities, and communication strategies to enhance provider and patient understanding and support for interventions proven to work best and deliver value in health care.

Core concepts and principles: For the purpose of the Roundtable activities, we define evidence-based medicine broadly to mean that, to the greatest extent possible, the decisions that shape the health and health care of Americans—by patients, providers, payers, and policy makers alike—will be grounded on a reliable evidence base, will account appropriately for individual variation in patient needs, and will support the generation of new insights on clinical effectiveness. Evidence is generally considered to be information from clinical experience that has met some established test of validity, and the appropriate standard is determined according to the requirements of the intervention and clinical circumstance. Processes that involve the development and use of evidence should be accessible and transparent to all stakeholders.

A common commitment to certain principles and priorities guides the activities of the Roundtable and its members, including the commitment to the right health care for each person; putting the best evidence into practice; establishing the effectiveness, efficiency, and safety of medical care delivered; building constant measurement into our healthcare investments; the establishment of healthcare data as a public good; shared responsibility distributed equitably across stakeholders, both public and private; collaborative stakeholder involvement in priority setting; transparency in the execution of activities and reporting of results; and subjugation of individual political or stakeholder perspectives in favor of the common good.

Page xiii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

Foreword

For decades, the rise in healthcare costs in the United States has outpaced growth in the economy as a whole. The United States spends per capita on health almost double the average of other Organisation for Economic Co-operation and Development countries. Over the years, it has become increasingly clear that Americans are not gaining benefits commensurate with these higher expenditures: dozens of countries today boast superior life expectancy and lower infant mortality.

Among many efforts to enhance value from health expenditures, the Institute of Medicine in 2006 created a Roundtable on Evidence-Based Medicine, now called the Roundtable on Value & Science-Driven Health Care. Its purpose was to bring together patients and consumers, providers, manufacturers, payers, researchers and policy makers in a neutral venue to discuss ways evidence about how well interventions work could transform delivery of care in this country. The Roundtable developed a vision of a learning healthcare system where evidence is both applied and generated as a natural course of care. Building on this work, the Roundtable convened leaders, researchers, and policy makers from across the healthcare field on November 17-18, 2008, for the workshop Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation.

This volume summarizes the presentations and discussions from the workshop. These explore the meaning of value in health care from a variety of perspectives, present methods to measure value, and describe ways to give value-enhancing incentives to the provider, consumer, manufacturer, payer, and other stakeholders in the healthcare system. The insights and ideas shared in this volume are germane to the healthcare reform efforts

Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

currently ongoing in this country and, specifically, can help achieve the dual goals of controlling healthcare expenditures and improving health outcomes.

I would like to offer my thanks to the members of the Roundtable who champion better health for Americans, to the Roundtable staff who coordinate and enable Roundtable activities, and to the sponsors who support this vital activity: the Agency for Healthcare Research and Quality, America’s Health Insurance Plans, AstraZeneca, Blue Shield of California Foundation, Burroughs Wellcome Fund, California Health Care Foundation, Centers for Medicare and Medicaid Services, Department of Veterans Affairs, Food and Drug Administration, Johnson & Johnson, the Moore Foundation, the National Institutes of Health, sanofi-aventis, and Stryker.


Harvey V. Fineberg, M.D., Ph.D.

President, Institute of Medicine

Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

Preface

Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation summarizes a two-day workshop held in November 2008, convened by the Institute of Medicine (IOM) Roundtable on Value & Science-Driven Health Care as part of its Learning Healthcare System workshop series. While the purpose of the workshop was not to yield a single definition of value, and, as a result, no single consistent definition of value was identified by the participants, this meeting did provide a forum for the broad spectrum of stakeholders in health to discuss the range of issues relevant to defining, assessing, and measuring the benefits received from our healthcare investments. This collection of papers and insights reflect the serious, reflective engagement of patients, providers, manufacturers, economists, payers, and employers—from both public and private sectors—in the central issues of value in health care. Participants discussed issues such as the mandate for improving value given rising expenditures on health care and the turbulent economic climate; the importance of perspective when defining value; the importance of communication between all involved stakeholders—but especially between patients, consumers, and providers—in order to improve outcomes while reducing costs; the tools available to incentivize value creation, including pay-for-performance, value-based insurance design, and electronic health records; and the opportunities and barriers for implementation and change.

The vision of the IOM Roundtable on Value & Science-Driven Health Care is to help foster the development of a learning healthcare system—a system in which the processes and information systems used throughout health care engineer both the natural delivery of best care practices and the

Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

real-time generation of new evidence. With the engagement and support of senior leadership from the nation’s key healthcare sectors, the work of the Roundtable has advanced this vision through concerted efforts, including public workshops and published proceedings. The focus of this workshop emerged from prior discussions among Roundtable members and participants which highlighted the nation’s lagging outcomes despite increasing expenditures on health—concerns which have only been underscored as the nation continues to battle economic turmoil. This workshop provided a forum for stakeholders to discuss their perspectives on value, discover areas of difference and commonality, and identify topics for further discussion and collaboration. As described in the Summary, a number of fundamental ideas about the impetus for change as well as the challenges, considerations, and opportunities paramount to achieving value emerged.

The workshop discussions made clear the belief in a compelling and urgent mandate to achieve greater value in health care. Yet participants also quickly identified the lack of a uniform definition of value to guide progress while also underscoring the importance of perspective, as value holds different meaning to different stakeholders. Challenges such as the fragmentation of the current service delivery system, a payment system that rewards volume over outcomes, and the lack of communication between patients, consumers, providers, and payers impede progress in targeting services to those most likely to benefit. Despite these challenges, participants seized the opportunity to explore utilization of existing efforts in the field. Presenters explored measurement tools in a variety of facets and specialties of medicine. Discussions focused on the possibilities of utilizing current tools such as health information technology, payment and reimbursement incentives, and organizational structures such as the medical home model as mechanisms for change. A clear concern was the preservation of incentives for innovation and the need to maintain a central focus on the patient as we proceed down the path towards value. The workshop also laid out a number opportunities and challenges requiring the attention and action of stakeholders such as those represented on the Roundtable, including the development of a comprehensive, coordinated system-wide approach to assess and improve the value of health care. The Roundtable will follow this workshop with deeper consideration of many of the highlighted issues through future workshops, commissioned papers, collaborative activities, and public communication efforts. While the challenges are significant, many opportunities exist for the committed members of Roundtable.

Multiple individuals and organizations donated their valuable time toward the development of this workshop summary. In particular, we would like to acknowledge the contributors to this volume for the insights they provided at the workshop as well as their efforts to develop their presentations into the manuscripts included in this summary publication.

Page xvii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

In this regard, we should emphasize that this summary is an assemblage of individually authored papers and is intended to convey only the views and beliefs of those participating in the workshop, not the express opinions of the Roundtable on Evidence-Based Medicine, its sponsors, or the Institute of Medicine. We would also like to acknowledge the counsel and efforts of the Planning Committee for this workshop, including Michael E. Chernew (Harvard Medical School), Ezekiel J. Emanuel (National Institutes of Health), Arthur Garson, Jr. (University of Virginia School of Medicine), Samuel R. Nussbaum (Wellpoint), John C. Rother (AARP), and Karen Smith (AstraZeneca). A number of IOM staff were instrumental in coordinating the two-day workshop, including Mark Peterson and Adam Schickedanz. Roundtable staff, including Pierre Yong, Kate Sharaf, LeighAnne Olsen, Catherine Zweig, Kate Vasconi, Ruth Strommen, Kiran Gupta, Jane Fredell, and Daniel O’Neill, helped to translate the workshop proceedings and discussion into this summary. Florence Poillon also contributed substantially to publication development. We would also like to thank Jackie Turner, Vilija Teel, Bronwyn Schrecker Jamrok, and Jordan Wyndelts for helping to coordinate the various aspects of review, production, and publication.

The issue of value looms only larger as we proceed into the twenty-first century. While progress has been made in recognizing the need to improve the clinical outcomes obtained for dollars spent on health care, further efforts need to be devoted to engender value as reality. We look forward to continuing the conversations started during this workshop, learning from its insights, and further contributing to the vision of The Learning Healthcare System.


Denis A. Cortese, M.D.

Chair, Roundtable on Value & Science-Driven Health Care


J. Michael McGinnis, M.D., M.P.P.

Executive Director, Roundtable on Value & Science-Driven Health Care

Page xviii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

This page intentionally left blank.

Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page xxii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×

This page intentionally left blank.

Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R1
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R2
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R3
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R4
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R5
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R6
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R7
Page viii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R8
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R9
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R10
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R11
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R12
Page xiii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R13
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R14
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R15
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R16
Page xvii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R17
Page xviii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R18
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R19
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R20
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R21
Page xxii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2010. Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/12566.
×
Page R22
Next: Summary »
Value in Health Care: Accounting for Cost, Quality, Safety, Outcomes, and Innovation: Workshop Summary Get This Book
×
Buy Paperback | $60.00 Buy Ebook | $47.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The United States has the highest per capita spending on health care of any industrialized nation. Yet despite the unprecedented levels of spending, harmful medical errors abound, uncoordinated care continues to frustrate patients and providers, and U.S. healthcare costs continue to increase. The growing ranks of the uninsured, an aging population with a higher prevalence of chronic diseases, and many patients with multiple conditions together constitute more complicating factors in the trend to higher costs of care.

A variety of strategies are beginning to be employed throughout the health system to address the central issue of value, with the goal of improving the net ratio of benefits obtained per dollar spent on health care. However, despite the obvious need, no single agreed-upon measure of value or comprehensive, coordinated systemwide approach to assess and improve the value of health care exists. Without this definition and approach, the path to achieving greater value will be characterized by encumbrance rather than progress.

To address the issues central to defining, measuring, and improving value in health care, the Institute of Medicine convened a workshop to assemble prominent authorities on healthcare value and leaders of the patient, payer, provider, employer, manufacturer, government, health policy, economics, technology assessment, informatics, health services research, and health professions communities. The workshop, summarized in this volume, facilitated a discussion of stakeholder perspectives on measuring and improving value in health care, identifying the key barriers and outlining the opportunities for next steps.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!